Global Brain Disease Market Research Report 2023

Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of brain diseases occur due to environmental factors. The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer’s, Huntington’s disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety, bipolar disorders, and others.  The etiology of brain disease is not specific. It can occur to anyone and the risk factors of brain diseases differ in accordance to the different types of brain diseases. The sign and symptoms also differ for every brain diseases. Some of the most common symptoms include headache, memory loss, tremors, increased reflexes, slurred speech, paralysis, and inability to concentrate among others. Moreover, the treatment of brain diseases range from surgery to rehabilitation to medications; depending upon the brain disease the patient is affected by. The brain diseases are progressive which may affect the daily life of patients and hence should be immediately treated upon their diagnosis or detection.

The global Brain Disease market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The incidence and prevalence of brain diseases and disorders increase with age. The growing baby booming population is the major factor driving the brain disease market, globally. Rising prevalence of brain diseases is expected to boost the growth of the market. Due lack of effective treatment for some brain diseases such as brain cancer, they are a huge demand for medicinal treatment. Because of this reason, key market players are intensively focusing on R&D to develop a safe and effective treatment for brain diseases. All these factors act as driver for burgeoning growth of the brain disease market. However, adverse effects associated with the medications of brain diseases is anticipated to hinder the market growth.

This report aims to provide a comprehensive presentation of the global market for Brain Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Disease.

The Brain Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brain Disease market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Brain Cancer

1.2.3 Alzheimer Disease

1.2.4 Alcoholism

1.2.5 Amnesia

1.2.6 Epilepsy

1.2.7 Meningitis

1.2.8 Others

1.3 Market by Application

1.3.1 Global Brain Disease Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals Pharmacy

1.3.3 Online Pharmacy

1.3.4 Pharmacy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Brain Disease Market Perspective (2018-2029)

2.2 Brain Disease Growth Trends by Region

2.2.1 Global Brain Disease Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Brain Disease Historic Market Size by Region (2018-2023)

2.2.3 Brain Disease Forecasted Market Size by Region (2024-2029)

2.3 Brain Disease Market Dynamics

2.3.1 Brain Disease Industry Trends

2.3.2 Brain Disease Market Drivers

2.3.3 Brain Disease Market Challenges

2.3.4 Brain Disease Market Restraints

3.1 Global Top Brain Disease Players by Revenue

3.1.1 Global Top Brain Disease Players by Revenue (2018-2023)

3.1.2 Global Brain Disease Revenue Market Share by Players (2018-2023)

3.2 Global Brain Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Brain Disease Revenue

3.4 Global Brain Disease Market Concentration Ratio

3.4.1 Global Brain Disease Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Disease Revenue in 2022

3.5 Brain Disease Key Players Head office and Area Served

3.6 Key Players Brain Disease Product Solution and Service

3.7 Date of Enter into Brain Disease Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Brain Disease Historic Market Size by Type (2018-2023)

4.2 Global Brain Disease Forecasted Market Size by Type (2024-2029)

5.1 Global Brain Disease Historic Market Size by Application (2018-2023)

5.2 Global Brain Disease Forecasted Market Size by Application (2024-2029)

6.1 North America Brain Disease Market Size (2018-2029)

6.2 North America Brain Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Brain Disease Market Size by Country (2018-2023)

6.4 North America Brain Disease Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Brain Disease Market Size (2018-2029)

7.2 Europe Brain Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Brain Disease Market Size by Country (2018-2023)

7.4 Europe Brain Disease Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Brain Disease Market Size (2018-2029)

8.2 Asia-Pacific Brain Disease Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Brain Disease Market Size by Region (2018-2023)

8.4 Asia-Pacific Brain Disease Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Brain Disease Market Size (2018-2029)

9.2 Latin America Brain Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Brain Disease Market Size by Country (2018-2023)

9.4 Latin America Brain Disease Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Brain Disease Market Size (2018-2029)

10.2 Middle East & Africa Brain Disease Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Brain Disease Market Size by Country (2018-2023)

10.4 Middle East & Africa Brain Disease Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Brain Disease Introduction

11.1.4 Pfizer Revenue in Brain Disease Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 Eli Lilly

11.2.1 Eli Lilly Company Detail

11.2.2 Eli Lilly Business Overview

11.2.3 Eli Lilly Brain Disease Introduction

11.2.4 Eli Lilly Revenue in Brain Disease Business (2018-2023)

11.2.5 Eli Lilly Recent Development

11.3 F. Hoffmann La Roche

11.3.1 F. Hoffmann La Roche Company Detail

11.3.2 F. Hoffmann La Roche Business Overview

11.3.3 F. Hoffmann La Roche Brain Disease Introduction

11.3.4 F. Hoffmann La Roche Revenue in Brain Disease Business (2018-2023)

11.3.5 F. Hoffmann La Roche Recent Development

11.4 GE Healthcare

11.4.1 GE Healthcare Company Detail

11.4.2 GE Healthcare Business Overview

11.4.3 GE Healthcare Brain Disease Introduction

11.4.4 GE Healthcare Revenue in Brain Disease Business (2018-2023)

11.4.5 GE Healthcare Recent Development

11.5 Janssen Pharmaceuticals

11.5.1 Janssen Pharmaceuticals Company Detail

11.5.2 Janssen Pharmaceuticals Business Overview

11.5.3 Janssen Pharmaceuticals Brain Disease Introduction

11.5.4 Janssen Pharmaceuticals Revenue in Brain Disease Business (2018-2023)

11.5.5 Janssen Pharmaceuticals Recent Development

11.6 Abbvie

11.6.1 Abbvie Company Detail

11.6.2 Abbvie Business Overview

11.6.3 Abbvie Brain Disease Introduction

11.6.4 Abbvie Revenue in Brain Disease Business (2018-2023)

11.6.5 Abbvie Recent Development

11.7 AC Immune

11.7.1 AC Immune Company Detail

11.7.2 AC Immune Business Overview

11.7.3 AC Immune Brain Disease Introduction

11.7.4 AC Immune Revenue in Brain Disease Business (2018-2023)

11.7.5 AC Immune Recent Development

11.8 Allergan

11.8.1 Allergan Company Detail

11.8.2 Allergan Business Overview

11.8.3 Allergan Brain Disease Introduction

11.8.4 Allergan Revenue in Brain Disease Business (2018-2023)

11.8.5 Allergan Recent Development

11.9 Merck

11.9.1 Merck Company Detail

11.9.2 Merck Business Overview

11.9.3 Merck Brain Disease Introduction

11.9.4 Merck Revenue in Brain Disease Business (2018-2023)

11.9.5 Merck Recent Development

11.10 Novartis

11.10.1 Novartis Company Detail

11.10.2 Novartis Business Overview

11.10.3 Novartis Brain Disease Introduction

11.10.4 Novartis Revenue in Brain Disease Business (2018-2023)

11.10.5 Novartis Recent Development

11.11 AstraZeneca

11.11.1 AstraZeneca Company Detail

11.11.2 AstraZeneca Business Overview

11.11.3 AstraZeneca Brain Disease Introduction

11.11.4 AstraZeneca Revenue in Brain Disease Business (2018-2023)

11.11.5 AstraZeneca Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Brain Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Brain Cancer

    Table 3. Key Players of Alzheimer Disease

    Table 4. Key Players of Alcoholism

    Table 5. Key Players of Amnesia

    Table 6. Key Players of Epilepsy

    Table 7. Key Players of Meningitis

    Table 8. Key Players of Others

    Table 9. Global Brain Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Brain Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 11. Global Brain Disease Market Size by Region (2018-2023) & (US$ Million)

    Table 12. Global Brain Disease Market Share by Region (2018-2023)

    Table 13. Global Brain Disease Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 14. Global Brain Disease Market Share by Region (2024-2029)

    Table 15. Brain Disease Market Trends

    Table 16. Brain Disease Market Drivers

    Table 17. Brain Disease Market Challenges

    Table 18. Brain Disease Market Restraints

    Table 19. Global Brain Disease Revenue by Players (2018-2023) & (US$ Million)

    Table 20. Global Brain Disease Market Share by Players (2018-2023)

    Table 21. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Disease as of 2022)

    Table 22. Ranking of Global Top Brain Disease Companies by Revenue (US$ Million) in 2022

    Table 23. Global 5 Largest Players Market Share by Brain Disease Revenue (CR5 and HHI) & (2018-2023)

    Table 24. Key Players Headquarters and Area Served

    Table 25. Key Players Brain Disease Product Solution and Service

    Table 26. Date of Enter into Brain Disease Market

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Brain Disease Market Size by Type (2018-2023) & (US$ Million)

    Table 29. Global Brain Disease Revenue Market Share by Type (2018-2023)

    Table 30. Global Brain Disease Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 31. Global Brain Disease Revenue Market Share by Type (2024-2029)

    Table 32. Global Brain Disease Market Size by Application (2018-2023) & (US$ Million)

    Table 33. Global Brain Disease Revenue Market Share by Application (2018-2023)

    Table 34. Global Brain Disease Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 35. Global Brain Disease Revenue Market Share by Application (2024-2029)

    Table 36. North America Brain Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. North America Brain Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 38. North America Brain Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Europe Brain Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Europe Brain Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 41. Europe Brain Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 42. Asia-Pacific Brain Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Asia-Pacific Brain Disease Market Size by Region (2018-2023) & (US$ Million)

    Table 44. Asia-Pacific Brain Disease Market Size by Region (2024-2029) & (US$ Million)

    Table 45. Latin America Brain Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Latin America Brain Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Latin America Brain Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Middle East & Africa Brain Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 49. Middle East & Africa Brain Disease Market Size by Country (2018-2023) & (US$ Million)

    Table 50. Middle East & Africa Brain Disease Market Size by Country (2024-2029) & (US$ Million)

    Table 51. Pfizer Company Detail

    Table 52. Pfizer Business Overview

    Table 53. Pfizer Brain Disease Product

    Table 54. Pfizer Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 55. Pfizer Recent Development

    Table 56. Eli Lilly Company Detail

    Table 57. Eli Lilly Business Overview

    Table 58. Eli Lilly Brain Disease Product

    Table 59. Eli Lilly Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 60. Eli Lilly Recent Development

    Table 61. F. Hoffmann La Roche Company Detail

    Table 62. F. Hoffmann La Roche Business Overview

    Table 63. F. Hoffmann La Roche Brain Disease Product

    Table 64. F. Hoffmann La Roche Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 65. F. Hoffmann La Roche Recent Development

    Table 66. GE Healthcare Company Detail

    Table 67. GE Healthcare Business Overview

    Table 68. GE Healthcare Brain Disease Product

    Table 69. GE Healthcare Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 70. GE Healthcare Recent Development

    Table 71. Janssen Pharmaceuticals Company Detail

    Table 72. Janssen Pharmaceuticals Business Overview

    Table 73. Janssen Pharmaceuticals Brain Disease Product

    Table 74. Janssen Pharmaceuticals Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 75. Janssen Pharmaceuticals Recent Development

    Table 76. Abbvie Company Detail

    Table 77. Abbvie Business Overview

    Table 78. Abbvie Brain Disease Product

    Table 79. Abbvie Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 80. Abbvie Recent Development

    Table 81. AC Immune Company Detail

    Table 82. AC Immune Business Overview

    Table 83. AC Immune Brain Disease Product

    Table 84. AC Immune Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 85. AC Immune Recent Development

    Table 86. Allergan Company Detail

    Table 87. Allergan Business Overview

    Table 88. Allergan Brain Disease Product

    Table 89. Allergan Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 90. Allergan Recent Development

    Table 91. Merck Company Detail

    Table 92. Merck Business Overview

    Table 93. Merck Brain Disease Product

    Table 94. Merck Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 95. Merck Recent Development

    Table 96. Novartis Company Detail

    Table 97. Novartis Business Overview

    Table 98. Novartis Brain Disease Product

    Table 99. Novartis Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 100. Novartis Recent Development

    Table 101. AstraZeneca Company Detail

    Table 102. AstraZeneca Business Overview

    Table 103. AstraZeneca Brain Disease Product

    Table 104. AstraZeneca Revenue in Brain Disease Business (2018-2023) & (US$ Million)

    Table 105. AstraZeneca Recent Development

    Table 106. Research Programs/Design for This Report

    Table 107. Key Data Information from Secondary Sources

    Table 108. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Brain Disease Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Brain Disease Market Share by Type: 2022 VS 2029

    Figure 3. Brain Cancer Features

    Figure 4. Alzheimer Disease Features

    Figure 5. Alcoholism Features

    Figure 6. Amnesia Features

    Figure 7. Epilepsy Features

    Figure 8. Meningitis Features

    Figure 9. Others Features

    Figure 10. Global Brain Disease Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 11. Global Brain Disease Market Share by Application: 2022 VS 2029

    Figure 12. Hospitals Pharmacy Case Studies

    Figure 13. Online Pharmacy Case Studies

    Figure 14. Pharmacy Case Studies

    Figure 15. Brain Disease Report Years Considered

    Figure 16. Global Brain Disease Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Brain Disease Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Brain Disease Market Share by Region: 2022 VS 2029

    Figure 19. Global Brain Disease Market Share by Players in 2022

    Figure 20. Global Top Brain Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Disease as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Brain Disease Revenue in 2022

    Figure 22. North America Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Brain Disease Market Share by Country (2018-2029)

    Figure 24. United States Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Brain Disease Market Share by Country (2018-2029)

    Figure 28. Germany Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Brain Disease Market Share by Region (2018-2029)

    Figure 36. China Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Brain Disease Market Share by Country (2018-2029)

    Figure 44. Mexico Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Brain Disease Market Share by Country (2018-2029)

    Figure 48. Turkey Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Brain Disease Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Pfizer Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 51. Eli Lilly Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 52. F. Hoffmann La Roche Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 53. GE Healthcare Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 54. Janssen Pharmaceuticals Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 55. Abbvie Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 56. AC Immune Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 57. Allergan Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 58. Merck Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 59. Novartis Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 60. AstraZeneca Revenue Growth Rate in Brain Disease Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed